SecBot SecBot
6-K ·Filed Jun 2, 2026

DRUG

BRIGHT MINDS BIOSCIENCES INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001062993-26-002975
Notable filing: 6-K
Actionable Insight • Neutral

This filing is purely administrative with no trading implications. Monitor future filings for clinical trial updates, financial results, or corporate developments that could affect the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
DRUG ▼ -0.20% at T+60d
NEUTRAL call -0.20% · α vs SPY -1.31% · entry $76.78 → $76.63
Entry = T+0 close
Jun 2, 2026
via day close
T+1d
-3.07%
call -3.07% · α -2.38%
$74.42
settled 5mo ago
T+5d
-11.70%
call -11.70% · α -8.73%
$67.80
settled 5mo ago
T+20d
-13.34%
call -13.34% · α -11.77%
$66.54
settled 4mo ago
T+60d
-0.20%
call -0.20% · α -1.31%
$76.63
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Bright Minds Biosciences Inc. filed a Form 6-K with the SEC on June 2, 2026, providing notice of its Annual General Meeting scheduled for March 31, 2026, with a record date of February 10, 2026. The filing is a routine procedural notification with no financial data, business updates, or material events disclosed.

Key Facts

  • Annual General Meeting scheduled for March 31, 2026.
  • Record date for notice and voting is February 10, 2026.
  • Meeting location is Vancouver, BC.
  • No financial results, guidance, or business developments were disclosed in the filing.
  • The filing was signed by CFO Ryan Cheung on June 2, 2026.

Financial Impact

No financial impact — filing contains only administrative meeting details.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001062993-26-002975
Document: form6k.htm0001062993-26-002975
Document: 0001062993-26-002975-index-headers.html0001062993-26-002975
Document: 0001062993-26-002975-index.html0001062993-26-002975
Document: 0001062993-26-002975.txt0001062993-26-002975
3 reports for DRUG
Performance horizon
Filters
Rows
Reports for DRUG — sortable, filterable
TypeNow
Oct 2, 2026
24d ago
6-K
NEUTRAL ★ 2/10
$49.79awaiting T+20—$53.93 (+8.31%)
Jun 3, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$74.42 $67.60▼ −9.16%▼ −8.16%$53.93 (−27.53%)
Jun 2, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$76.78 $66.54▼ −13.34%▼ −11.77%$53.93 (−29.76%)
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026